Concepedia

Publication | Closed Access

BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer

DOI

41

Citations

12

References

2020

Year

Nicolas Epaillard, Audrey Simonaggio, Réza Elaidi, Fouzia Azzouz, E. Braychenko, Constance Thibault, Cheng‐Ming Sun, Marco Moreira, Stéphane Oudard, Yann Vano
Bulletin du Cancer

References

YearCitations

Page 1